L & S Advisors’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
L & S Advisors's GILD Position: Q2 2026 in Review
L & S Advisors sold out of Gilead Sciences (GILD) in Q2 2026, closing a stake of 75,255 shares — an estimated $10.5M sold.
L & S Advisors first reported a position in GILD in Q2 2013 and held it in 14 quarters. The position peaked at $10.5M in Q1 2026. 2,279 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- L & S Advisors reported no remaining Gilead Sciences position as of Q2 2026 after selling out during the quarter.
- L & S Advisors sold 75,255 Gilead Sciences shares in Q2 2026, an estimated $10.5M.
- L & S Advisors first reported a position in Gilead Sciences in Q2 2013 and held it in 14 quarters.
- L & S Advisors's Gilead Sciences position peaked at $10.5M in Q1 2026.
- 2,279 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on L & S Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.